NCT00339157View on ClinicalTrials.gov

Interleukin-1 Receptor Antagonist (IL-1RA) (ANAKINRA) IN SEVERE SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2006

Study Completion Date

July 31, 2008

Conditions

Systemic-Onset Juvenile Idiopathic Arthritis

Interventions

DRUG

Anakinra

BIOLOGICAL

Pneumo23

Trial Locations (6)

33000

Bordeaux CHU, Bordeaux

54511

Nancy Hopital d'Enfants, Nancy

69437

Hopital Lyon Edouard Herriot, Lyon

75015

Pediatric Immuno-Hematology and Rheumatology Unit, Necker-Enfants Malades Hospital, 149 rue de Sevres, Paris

75019

Robert Debre Hospital, Paris

94270

Kremlin-Bicetre Hospital, Le Kremlin-Bicêtre

All Listed Sponsors

lead

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

NCT00339157 - Interleukin-1 Receptor Antagonist (IL-1RA) (ANAKINRA) IN SEVERE SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS | Biotech Hunter | Biotech Hunter